The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.
54 Biggest Movers From Yesterday
Gainers
MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday.
GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50.
Analyst Ratings For LogicBio Therapeutics
Over the past 3 months, 4 analysts have published their opinion on LogicBio Therapeutics (NASDAQ:LOGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Chardan Capital Maintains Hold on LogicBio Therapeutics, Lowers Price Target to $6
Chardan Capital analyst Geulah Livshits maintains LogicBio Therapeutics (NASDAQ:LOGC) with a Hold and lowers the price target from $16 to $6.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 18 companies made new 52-week lows.
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ:
